EVEREST study report 3: diagnostic challenges of polypoidal choroidal vasculopathy. Lessons learnt from screening failures in the EVEREST study

• Main Authors: Tan, C.S, Ngo, W.K, Lim, L.W, Tan, N.W, Lim, T.H, on behalf of the EVEREST Study Group
• Other Authors: OPHTHALMOLOGY
• Format: Article
• Published: Springer Verlag 2020
• Subjects: adult; age related macular degeneration; aged; angioma; Article; clinical article; diagnostic error; female; human; indocyanine green angiography; male; microaneurysm; middle aged; multicenter study (topic); phase 4 clinical trial (topic); polypoidal choroidal vasculopathy; priority journal; randomized controlled trial (topic); retina detachment; retinal angiomatous proliferation; subretinal neovascularization; very elderly; young adult; adolescent; antagonists and inhibitors; Choroidal Neovascularization; clinical trial; controlled study; double blind procedure; fluorescence angiography; macular degeneration; multicenter study; phase 4 clinical trial; photochemotherapy; Polyps; randomized controlled trial; angiogenesis inhibitor; coloring agent; indocyanine green; porphyrin; ranibizumab; vasculotropin A; VEGFA protein, human; verteporfin; Adolescent; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Coloring Agents; Diagnostic Errors; Double-Blind Method; Female; Fluorescein Angiography; Humans; Indocyanine Green; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Porphyrins; Ranibizumab; Vascular Endothelial Growth Factor A
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/179289
• Institution: National University of Singapore

10.1007/s00417-016-3333-y